WIDDER KENNETH J 4

What Happened

• Kenneth J. Widder, a member of QuidelOrtho Corporation's Board of Directors, was awarded a total of 24,185 restricted stock units (RSUs) on June 25, 2026. The award shows $0.00 as the acquisition price because RSUs are a derivative compensation award (each RSU represents the right to one share). The grants were made in lieu of cash board/retainer fees under the company's deferred compensation program.

Key Details

• Transaction date: June 25, 2026 (Filed: June 29, 2026; filing appears timely)
• Awards: 15,532 RSUs, 6,656 RSUs, and 1,997 RSUs (total = 24,185 RSUs); acquisition code = A (award/grant)
• Price: $0.00 listed (typical for RSU awards; value realized when/if RSUs vest and convert to shares)
• Vesting/terms noted in filing:
  • Footnote: each RSU = right to one common share.
  • Some RSUs vest on specific dates (e.g., 1,664 vested on 6/25/2026; 1,664 will vest 9/25/2026; 1,664 on 12/25/2026; 1,664 on 3/25/2027).
  • Other RSUs are noted to vest on June 25, 2027; release of vested RSUs follows the director’s elected deferral schedule.
• Shares owned after transaction: not specified in the filing excerpt provided.
• Transaction code: A = award/grant. This is compensation, not an open-market purchase or sale.

Context

• RSUs are a form of deferred compensation that convert to actual shares only upon vesting or release; they do not represent an immediate cash purchase or sale and should be viewed as compensation rather than a direct bullish/bearish market signal.
• Because these RSUs were issued in lieu of cash retainers under a deferred compensation program, they reflect routine director compensation rather than an opportunistic market trade.